Skip to main content

Table 1 Enrolment characteristics by care start cohort

From: Trends in clinical characteristics and outcomes of Pre-ART care at a large HIV clinic in Nairobi, Kenya: a retrospective cohort study

Year of enrolment

2004–05

2006–07

2008–09

2010–11

2012–13

2014–15

Overall

Chi Square for trend p value

n = 789

n = 1435

n = 1538

n = 1438

n = 1830

n = 1600

n = 8630

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Gender

Female n (%)

493 (62.5)

920 (64.1)

995 (64.7)

914 (63.6)

1118 (61.1)

968 (60.5)

5408 (62.7)

0.0106

Age (in yrs.)

 

Mean (sd)

38.2 (8.6) 

38.3 (9.0) 

37.6 (9.5) 

37.3 (9.8) 

37.3 (10.0) 

36.8 (10.7) 

37.5 (9.7) 

Median (IQR)

37 (32–43)

37 (32–44)

37 (31–43)

36 (30–43)

37 (30–44)

36 29–44) 

37 (31–44) 

Age group n (%)

15–19

3 (0.4)

8 (0.6)

21 (1.4)

19 (1.3)

44 (2.4)

45 (2.8)

140 (1.6)

0.0001

20–24

14 (1.8)

46 (3.2)

66 (4.3)

93 (6.5)

118 (6.5)

143 (8.9)

480 (5.6)

25–34

275 (34.9)

478 (33.3)

528 (34.4)

506 (35.2)

583 (31.9)

514 (32.1)

2884 (33.4)

35–44

335 (42.5)

587 (40.9)

590 (38.3)

505 (35.1)

663 (36.2)

525 (32.8)

3205 (37.2)

45–54

121 (15.4)

239 (16.7)

254 (16.5)

233 (16.2)

328 (18)

282 (17.6)

1457 (16.9)

55+

41 (5.2)

77 (5.4)

79 (5.1)

82 (5.7)

94 (5.1)

91 (5.7)

464 (5.4)

Marital status n (%)

Single

159 (20.2)

281 (19.6)

295 (19.2)

339 (23.6)

500 (27.3)

477 (29.8)

2051 (23.8)

0.0034

Married

473 (60)

837 (58.3)

942 (61.3)

834 (58)

946 (51.7)

738 (46.1)

4770 (55.3)

Divorced/separated

38 (4.8)

105 (7.3)

93 (6.1)

90 (6.3)

169 (9.2)

171 (10.7)

666 (7.7)

Widowed

91 (11.5)

165 (11.5)

152 (9.9)

116 (8.1)

171 (9.3)

142 (8.9)

837 (9.7)

Not documented

28 (3.6)

47 (3.3)

56 (3.6)

59 (4.1)

44 (2.4)

72 (4.5)

306 (3.6)

Residency n (%)

Rural

185 (23.5)

257 (17.9)

296 (19.3)

187 (13.0)

186 (10.2)

62 (3.9)

1173 (13.6)

0.0001

Urban

537 (68.1)

1081 (75.3)

1145 (74.5)

1182 (82.2)

1444 (78.9)

1362 (85.1)

6751 (78.2)

Not documented

67 (8.5)

97 (6.8)

97 (6.3)

69 (4.8)

200 (10.9)

176 (11.0)

706 (8.2)

Patient source n (%)

VCT

271 (34.4)

588 (41)

650 (42.3)

628(4 3.7)

793 (43.3)

812(5 0.8)

3742 (43.4)

0.0001

PMTCT

202 (25.6)

296 (20.6)

293 (19.1)

232 (16.1)

159 (8.7)

107 (6.7)

1289 (14.9)

TB clinic

87 (11)

189 (13.2)

164 (10.7)

189 (13.1)

90 (4.9)

1 (0.1)

720 (8.3)

In-patient

59 (7.5)

114 (7.9)

129 (8.4)

98 (6.8)

174 (9.5)

190 (11.9)

764 (8.9)

Out-patient

9 (1.1)

16 (1.1)

14 (0.9)

22 (1.5)

63 (3.4)

11 (0.7)

135 (1.6)

Other facility

13 (1.7)

32 (2.2)

29 (1.9)

28 (2)

169 (9.2)

32 (2)

303 (3.5)

Other source

42 (5.3)

67 (4.7)

85 (5.5)

69 (4.8)

215 (11.8)

416(26)

894 (10.4)

Not documented

106 (13.4)

133 (9.3)

174 (11.3)

172 (12)

167 (9.1)

31 (1.9)

783 (9.1)

HIV diagnosis n(%)

YoEnr ≠ YoDg

48 (6.1)

163 (11.4)

226 (14.7)

247 (17.2)

343 (18.7)

234 (14.6)

1261 (14.6)

0.0412

YoEnr = YoDg

345 (43.7)

737 (51.4)

760 (49.4)

684 (47.6)

787 (43.0)

588 (36.8)

3901 (45.2)

YoDg not documented

396 (50.2)

535 (37.3)

552 (35.9)

507 (35.3)

700 (38.3)

778 (48.6)

3468 (40.2)

Clinical stage n (%)

Stage 1&2

305 (38.7)

650 (45.3)

890 (57.9)

899 (62.5)

1043 (57)

915 (57.2)

4702 (54.5)

0.0001

Stage 3&4

448 (56.8)

742 (51.7)

608 (39.5)

501 (34.8)

600 (32.8)

440 (27.5)

3339 (38.7)

Not documented

36 (4.6)

43 (3)

40 (2.6)

38 (2.6)

187 (10.2)

245 (15.3)

589 (6.8)

CD4 count

Median (IQR)

178 (67–330)

197 (80–380)

273 (128–458)

320 (158–507)

279 (111–490)

259 (101–483)

(257) (109–460)

 

CD4 group n (%)

0–100

145 (18.4)

303 (21.1)

192 (12.5)

170 (11.8)

332 (18.1)

290 (18.1)

1432 (16.6)

0.0001

101–200

86 (10.9)

214 (14.9)

166 (10.8)

182 (12.7)

232 (12.7)

189 (11.8)

1069 (12.4)

201–250

50 (6.3)

67 (4.7)

89 (5.8)

86 (6)

106 (5.8)

92 (5.8)

490 (5.7)

251–350

43 (5.5)

142 (9.9)

145 (9.4)

156 (10.9)

188 (10.3)

148 (9.3)

822 (9.5)

351–500

51 (6.5)

140 (9.8)

166 (10.8)

216 (15)

241 (13.2)

168 (10.5)

982 (11.4)

>500

47 (6)

159 (11.1)

194 (12.6)

288 (20)

341 (18.6)

285 (17.8)

1314 (15.2)

Not documented

367 (46.5)

410 (28.6)

586 (38.1)

340 (23.6)

390 (21.3)

428 (26.8)

2521 (29.2)

Opportunistic infections n (%)

TB

91 (11.5)

178 (12.4)

161 (10.5)

144 (10)

231 (12.6)

133 (8.3)

938 (10.9)

0.0726

PCP

33 (4.2)

60 (4.2)

73 (4.8)

74 (5.2)

89 (4.9)

26 (1.6)

355 (4.1)

0.0271

Cryptococcal disease

4 (0.5)

8 (0.6)

16 (1)

9 (0.6)

15 (0.8)

9 (0.6)

61 (0.7)

0.7077

Oral candidiasis

59 (7.5)

106 (7.4)

42 (2.7)

38 (2.6)

38 (2.1)

35 (2.2)

318 (3.7)

0.0001

Oesophageal candidiasis

1 (0.1)

8 (0.6)

6 (0.4)

11 (0.8)

4 (0.2)

7 (0.4)

37 (0.4)

0.9132

Kaposi’s sarcoma

12 (1.5)

12 (0.8)

20 (1.3)

12 (0.8)

8 (1)

11 (0.7)

85 (1)

0.1126

Other OIa

197 (25)

423 (29.5)

441 (28.7)

502 (34.9)

648 (35.4)

402 (25.1)

2613 (30.3)

0.0162

Any OIb

301 (38.2)

601 (41.9)

617 (40.1)

656 (45.6)

863 (47.2)

519 (32.4)

3557 (41.2)

0.8563

Presenting symptoms n (%)

Abdominal pain

38 (4.8)

53 (3.7)

55 (3.6)

57 (4)

76 (4.2)

85 (5.3)

364 (4.2)

0.089

Headache

50 (6.3)

75 (5.2)

97 (6.3)

84 (5.8)

111 (6.1)

116 (7.3)

533 (6.2)

0.21

Cough

167 (21.2)

206 (14.4)

264 (17.2)

217 (15.1)

315 (17.2)

284 (17.8)

1453 (16.8)

0.8723

Chest pain

47 (6)

1 (2.9)

68 (4.4)

46 (3.2)

65 (3.6)

74 (4.6)

341 (4)

0.6866

Any symptom

389 (49.3)

643 (44.8)

662 (43)

526 (36.6)

813 (44.4)

862 (53.9)

3895 (45.1)

0.0369

  1. Italic values indicate overall summary statistics
  2. VCT voluntary counselling and testing; PCP pneumocystis carinii pneumonia
  3. aOther OIs includes all major and minor OIs not listed in table PMTCT prevention of mother to child transmission
  4. bAny OIs includes both OIs listed and not listed in table TB tuberculosis